Dongwha Pharm.Co.,Ltd (KRX:000020)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,890.00
+60.00 (0.88%)
At close: Jul 10, 2025, 3:30 PM KST

Dongwha Pharm.Co.,Ltd Revenue

Dongwha Pharm.Co.,Ltd had revenue of 125.67B KRW in the quarter ending March 31, 2025, with 5.71% growth. This brings the company's revenue in the last twelve months to 471.66B, up 23.93% year-over-year. In the year 2024, Dongwha Pharm.Co.,Ltd had annual revenue of 464.87B with 28.74% growth.

Revenue (ttm)
471.66B
Revenue Growth
+23.93%
P/S Ratio
0.41
Revenue / Employee
578.02M
Employees
816
Market Cap
191.53B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 464.87B 103.77B 28.74%
Dec 31, 2023 361.11B 20.68B 6.08%
Dec 31, 2022 340.43B 47.41B 16.18%
Dec 31, 2021 293.02B 20.94B 7.70%
Dec 31, 2020 272.08B -35.07B -11.42%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2012 Pro Pro Pro
Dec 31, 2011 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings